PTC Therapeutics
PTCT
#2687
Rank
โ‚น557.22 B
Marketcap
โ‚น6,940
Share price
-0.76%
Change (1 day)
69.33%
Change (1 year)

Earnings for PTC Therapeutics (PTCT)

Earnings in 2025 (TTM): โ‚น63.20 Billion

According to PTC Therapeutics 's latest financial reports the company's current earnings are โ‚น1.77 Billion. In 2024 the company made an earning of -โ‚น32.63 Billion, an increase over its 2023 earnings that were of -โ‚น62.54 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for PTC Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น63.20 B-293.76%
2024 -โ‚น32.63 Billion-47.84%
2023 -โ‚น62.54 Billion18.49%
2022 -โ‚น52.78 Billion13.34%
2021 -โ‚น46.57 Billion28.64%
2020 -โ‚น36.2 Billion67.94%
2019 -โ‚น21.56 Billion87.28%
2018 -โ‚น11.51 Billion64.95%
2017 -โ‚น6.98 Billion-45.13%
2016 -โ‚น12.72 Billion-16.72%
2015 -โ‚น15.27 Billion72.64%
2014 -โ‚น8.85 Billion90.89%
2013 -โ‚น4.64 Billion96.58%
2012 -โ‚น2.36 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vertex Pharmaceuticals
VRTX
โ‚น400.80 B 502.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น22.66 Billion-134.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-โ‚น14.38 Billion-121.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
-โ‚น49.4 Billion-174.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น12.4 Billion-118.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.475 T 2,115.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland